MENU
ORIC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Oric Pharmaceuticals (ORIC) Ownership - Who owns Oric Pharmaceuticals?
Profile
Industry
N/A
Address
240 E. Grand Avenue
Phone
+1 650 388-5600
Employees
100
Web
https://www.oricpharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
723.77M
P/E Ratio
N/A
Total Cash
286.41M
Projected Growth
N/A
Total Debt
2.77M
Revenue
N/A
Risk (Beta)
1.01
Dividend Yield
N/A
Total Cash/Share
4.06
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ORIC
Capitalization
724M
P/E Ratio
N/A
Risk (Beta)
1.01
Dividend Yield
N/A
Total Cash
286M
Total Cash/Share
4.06
Total Debt
2.77M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
302M
P/B Ratio
2.39
Cash Flow
N/A
Earnings
-1.76
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7K
Current Ratio
15.08
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-124.06M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-35.69
Shares Held By Institutions
639M
Shares Outstanding - Current
70.5M
Total Liabilities
26.5M
Total Volume MTD
N/A
Value
1
Gain YTD
11.522
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical stage company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
240 E. Grand Avenue
Phone
+1 650 388-5600
Employees
100
Web
https://www.oricpharma.com